In vivo contribution of Cyp24a1 promoter vitamin D response elements.

Cyp24a1 Cyp27b1 1 25(OH)2D3 25(OH)D3 Cytochrome P450 vitamin D

Journal

Endocrinology
ISSN: 1945-7170
Titre abrégé: Endocrinology
Pays: United States
ID NLM: 0375040

Informations de publication

Date de publication:
04 Oct 2024
Historique:
received: 27 08 2024
revised: 24 09 2024
accepted: 02 10 2024
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 3 10 2024
Statut: aheadofprint

Résumé

CYP24A1 is a multifunctional, P450 mitochondrial enzyme that catabolizes the vitamin D hormone (calcitriol, 1,25(OH)2D3), its precursor (calcifediol, 25(OH)D3), and numerous vitamin D metabolites. In the kidney, Cyp24a1 is induced by 1,25(OH)2D3 and FGF23, and potently suppressed by PTH to control the circulating levels of 1,25(OH)2D3. Cyp24a1 is controlled by a pair of promoter proximal (PRO) vitamin D response elements (VDREs) that are aided by distal, downstream (DS) enhancers. The DS1 enhancer is kidney-specific and responsible for PTH and FGF23 actions, and the DS2 enhancer responds to 1,25(OH)2D3 in all tissues. Despite this knowledge, in vivo contributions of the PRO VDREs to basal expression, FGF23 activation, and PTH suppression of Cyp24a1, remain unknown. Here in this study, we selectively mutated the PRO VDREs in the mouse to address these questions. We found mutation of the VDREs leads to a dramatic loss of VDR occupancy, a reduction of 1,25(OH)D3-induced kidney Cyp24a1 expression, and near elimination of intestinal Cyp24a1 induction. FGF23 induction of Cyp24a1 was reduced, but not eliminated and still showed a synergistic increase with 1,25(OH)2D3. PTH suppression of Cyp24a1 was unchanged, despite minor reductions in total pCREB occupancy. Finally, VDR recruitment was dramatically reduced across the DS enhancers in the Cyp24a1 locus. Taken together, our data suggest a cooperative relationship between the DS and PRO enhancers in the regulation of Cyp24a1 by 1,25(OH)2D3 and FGF23, and points to the DS1 region as a crucial basal switch for Cyp24a1 activity that further defines the interconnected genomic control in vitamin D catabolism.

Identifiants

pubmed: 39363152
pii: 7810261
doi: 10.1210/endocr/bqae134
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.

Auteurs

Mark B Meyer (MB)

Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI 53706, U.S.A.

Seong Min Lee (SM)

Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI 53706, U.S.A.

Jordan M Towne (JM)

Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI 53706, U.S.A.

Shannon R Cichanski (SR)

Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI 53706, U.S.A.

Martin Kaufmann (M)

Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada K7L3N6.
Department of Surgery, Queen's University, Kingston, Ontario, Canada K7L3N6.

Glenville Jones (G)

Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada K7L3N6.

J Wesley Pike (JW)

Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, U.S.A.

Classifications MeSH